just after mkt opened i placed an odd sized bid @ 695 (i

New Post Public Reply Private Reply Replies (2) Message Board
4kids 4kids #38584
265
just after mkt opened i placed an odd sized bid @ 695 (i jumped 69c bid) .. i do the odd sized bids .. usually .. because i want to see how *handled* via the daily tape of trades .. they (NR non retail) are literally rolling resets right now imo

so this was the bid .. (2005 @ .695c)


Action Buy
Quantity 2,005 Shares
Route KNIGHT EQUITY MARKETS, L.P.
Order Type Limit at $0.695
Time in Force Day
Order Expiration 04:00 PM ET
Conditions None
Trade Type Cash
Market Session Standard
Order Date 10/26/2017, 09:33:52 AM ET
Cancel Date
Executions for This Trade

Date
Time
Price
Quantity
Amount
10/26/2017 09:36:00 AM ET $0.695 2,005.000 $1,393.48


now note correlation to 9:36AM time stamp ..


09:46:19 0.70 2000 OTO
09:43:56 0.71 2668 OTO
09:43:06 0.71 100 OTO
09:42:49 0.70 800 OTO
09:42:44 0.71 200 OTO
09:37:26 0.70 100 OTO
09:37:26 0.6995 1000 OTO
09:37:23 0.70 897 OTO
09:37:14 0.70 2500 OTO .. mirrored trade?? done @ 70c above 695c
09:36:25 0.70 500 OTO
09:36:00 0.695 2500 OTO ** my 2005 bundled into @ bid (offset = 495)
09:33:37 0.70 500 OTO
09:33:19 0.70 1400 OTO
09:32:42 0.695 150 OTO
09:31:04 0.70 2000 OTO
09:30:01 0.6975 133 OTO .. hidden @ mkt open


now note the B/A .. and the 5 showing via Nite on bid @ 70c .. coincidence? perhaps .. but perhaps not



NITE 0.70 6,405 09:59
CDEL 0.70 2,400 10:03
ETRF 0.70 2,050 09:45
LAFC 0.685 1,000 10/25
CSTI 0.68 10,000 09:30
VERT 0.675 1,000 10/25
CANT 0.62 1,000 08:30
STXG 0.60 1,000 10/05
VNDM 0.55 1,000 10/25
PUMA 0.55 1,000 08:10
MAXM 0.0001 10,000 07:35

CDEL 0.7049 1,000 10:03
ETRF 0.705 1,000 09:57
NITE 0.71 2,200 10:02
CANT 0.723 1,000 08:30
VERT 0.723 1,000 09:37
CSTI 0.725 1,000 08:30
LAFC 0.73 1,000 09:30
VNDM 0.76 1,000 10/25
PUMA 1.00 200 09:30
STXG 2.00 100 10/05
MAXM 8.00 100 07:35

as of this post .. and this is what i refer to as NR *CONtrolling* outcome *as able* to .. the day NR loses control .. will be a sight to behold and document

Detailed Quote:IPIX
INNOVATION PHARMACEUTICALS INC
0.70Up 0.00 (0.00 %)AS OF 10:03:33AM ET 10/26/2017

Last Trade 0.70
Trade Time 10:03:33am ET

Change 0.00
% Change 0.00%

Bid 0.70
Bid Size 1085[u]5[/u]

Ask 0.7049
Ask Size 1000


Open 0.6975
Day High 0.71
Day Low 0.695
Previous Close
10/25/2017 0.70
52-Week High
11/22/2016 1.505
52-Week Low
05/10/2017 0.63

Price Performance (Last 52 Weeks)
10/25/2017 -40.17%

Volume 27,848
Volume (10 day Average) 137,283
Volume (90 day Average) 180,470

will post weekly tape of trades .. EOW ..

as always kudos to Innovation's mgmt for *awareness*

4kids









Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 0

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 0

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 0

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 5

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 0

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

AI Alliance Introduces Game-Changing Tools and Expands

Updated Category News Views 289

AI Alliance Launches Innovative Programming Language and Framework Today marked a significant advancement in the world of artificial intelligence as the AI Alliance, a global non-profit organization committed to the evolution of open-source AI, unveiled groundbreaking initiatives. The introduction of Dana, an AI-powered programming language, alongside the OpenDXA agent...

Continue Reading
FDA Approves Repatha for Adults with High LDL-C Risks

Updated Category News Views 245

FDA Broadens Repatha Approval for Cardiovascular Risk Recently, the FDA has expanded the therapeutic indications for Repatha (evolocumab), allowing it to be prescribed to adults at a heightened risk of major adverse cardiovascular events (MACE) due to uncontrolled low-density lipoprotein cholesterol (LDL-C), often referred to as 'bad cholesterol.' This significant update...

Continue Reading
Nikola Corp Strengthens Financial Strategy with Updated Equity Deal

Updated Category News Views 116

Nikola Corporation's Strategic Financial Update Nikola Corporation (NASDAQ:NKLA), renowned for its commitment to zero-emission vehicle manufacturing, has made significant adjustments to its equity distribution agreement with Citigroup Global Markets Inc. This change was detailed in a recent filing, affirming the company's proactive approach to managing its financial...

Continue Reading
Exploring the Future of the Emergency Food Market Growth

Updated Category News Views 243

Understanding the Emergency Food Market Expansion The global emergency food market is on the brink of a significant transformation as it is projected to grow by an impressive USD 3.20 billion over the period from 2024 to 2028. With a compound annual growth rate (CAGR) of approximately 7.35%, this market is witnessing a shift driven by the organized retail sector's growth...

Continue Reading
Innovative Robotics: KEENON Launches Humanoid and Lawn Mower

Updated Category News Views 166

KEENON Robotics Makes Waves at CES with New Innovations At the recent tech event, KEENON Robotics, a pioneer in the field of service robotics, took center stage by unveiling its latest creations: the humanoid robot XMAN-R1 and the fully autonomous lawn mower known as KEENMOW K1. This showcase reflects KEENON's commitment to innovation and its mission to improve everyday...

Continue Reading